Read More

Recap: Corbus Pharmaceuticals Q1 Earnings

  Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share increased 67.44% year over year to ($0.14), which beat the estimate of ($0.15).

CRBP